Financial Performance - The company's operating revenue for Q3 2025 was approximately ¥9.88 billion, a decrease of 5.46% compared to the same period last year[6]. - The total profit for the quarter was approximately ¥1.12 billion, down 1.89% year-on-year, while the net profit attributable to shareholders increased by 4.52% to approximately ¥821.33 million[6][7]. - The net profit attributable to shareholders, excluding non-recurring gains and losses, was approximately ¥612.46 million, reflecting a year-on-year increase of 5.20%[9]. - Cash flow from operating activities for the quarter was approximately ¥1.25 billion, an increase of 15.57% compared to the same period last year[6]. - The basic and diluted earnings per share for the quarter were both ¥0.31, representing a year-on-year increase of 6.90%[6]. - For the first three quarters of 2025, the company achieved operating revenue of CNY 29.393 billion, a decrease compared to the same period last year[18]. - The net profit attributable to shareholders for the first three quarters of 2025 was CNY 2.523 billion, with a net profit of CNY 1.573 billion after deducting non-recurring gains and losses[18]. - Total operating revenue for the first three quarters of 2025 was CNY 29.39 billion, a decrease of 4.9% compared to CNY 30.91 billion in the same period of 2024[37]. - Net profit for the first three quarters of 2025 reached CNY 3.06 billion, an increase of 21.3% from CNY 2.52 billion in the first three quarters of 2024[37]. - Total comprehensive income for the period attributable to the parent company was CNY 2,242,462,807.32, an increase from CNY 1,833,394,697.38 in the same period last year, representing a growth of approximately 22.3%[38]. - Basic and diluted earnings per share increased to CNY 0.95 from CNY 0.75, reflecting a growth of 26.7% year-over-year[38]. Assets and Liabilities - The total assets of the company as of September 30, 2025, were approximately ¥118.12 billion, a slight increase of 0.56% from the end of the previous year[6]. - The equity attributable to shareholders was approximately ¥48.03 billion, up 1.62% from the end of the previous year[6]. - The company's total assets as of September 30, 2025, amounted to CNY 118.12 billion, slightly up from CNY 117.46 billion at the end of 2024[36]. - Total liabilities decreased to CNY 57.31 billion from CNY 57.53 billion year-over-year[36]. - The company’s long-term equity investments increased to CNY 26.38 billion from CNY 24.69 billion, reflecting a growth of 6.8%[36]. - The company’s total equity increased to CNY 60.81 billion from CNY 59.93 billion, indicating a growth of 1.5% year-over-year[36]. - Total liabilities increased to CNY 15,795,860,646.14 from CNY 14,947,230,943.39, representing an increase of approximately 5.7%[44]. - The total equity attributable to shareholders decreased to CNY 35,567,203,718.02 from CNY 35,728,698,458.71, a decline of about 0.45%[44]. Research and Development - Research and development expenses for the first three quarters of 2025 totaled CNY 2.730 billion, an increase of 3.08% year-on-year[19]. - The company’s total R&D investment for the first three quarters of 2025 was CNY 3.998 billion, reflecting a growth of 2.12% year-on-year[19]. - In Q3 2025, R&D expenses reached CNY 1.013 billion, marking a significant increase of 28.81% year-on-year[19]. - The company continues to focus on innovative drugs and high-end medical devices, aiming to optimize asset and financial structures through lean operations[18]. - The company’s innovative drug pipeline continues to expand, with multiple products in various stages of clinical trials and regulatory approvals[26]. - The company aims to enhance treatment options for patients with advanced cancers through its ongoing research and development efforts[21]. Shareholder Information - The controlling shareholder, Fosun High Technology, held a total of 961.424 million shares, accounting for approximately 36.00% of the total share capital at the end of the reporting period[16]. - The top ten shareholders collectively held 1.5 billion shares, with Fosun High Technology being the largest shareholder[15]. - The company completed the repurchase of 14,228,552 A shares, accounting for approximately 0.5328% of the total share capital, with a total repurchase amount of approximately RMB 348.36 million, at an average price of RMB 24.48 per share[30]. - The company repurchased 3,410,500 H shares, representing about 0.1277% of the total share capital, with a total repurchase amount of approximately HKD 47.84 million, at an average price of HKD 14.03 per share[31]. - The company approved an A-share stock option incentive plan, granting up to 5,726,100 A-share options, with the first grant not exceeding 4,580,900 options[33]. - The company approved an H-share restricted stock unit plan, granting up to 13,370,500 H-share restricted stock units, with the first grant not exceeding 10,696,400 units[34]. Regulatory Approvals and Product Development - The company received approval for a new indication of its innovative small molecule CDK4/6 inhibitor, FCN-437c, for the treatment of HR-positive, HER2-negative locally advanced or metastatic breast cancer in China[21]. - The company’s HLX14 injection was approved by the FDA and the European Commission, covering all indications previously approved for the original product, making it the first domestically produced HLX14 to gain overseas approval[22]. - The company’s innovative PD-1 inhibitor, SRL-172, achieved its primary endpoint in a Phase III clinical study for gastric cancer, supporting early market application[23]. - The company established a nuclear medicine platform, Xingrui Jingxuan, to develop integrated diagnostic and therapeutic nuclear medicine products targeting the oncology field[24]. - The company submitted a registration application for FKC889 injection for the treatment of relapsed or refractory precursor B-cell acute lymphoblastic leukemia (ALL) in adults, which was accepted by the National Medical Products Administration in September 2025[22]. - The company’s HLX43 injection received orphan drug designation from the FDA for the treatment of thymic epithelial tumors, aiding its subsequent development and commercialization in the U.S.[23]. - The company is preparing clinical trials for Ga[68Ga]PSMA-0057 and Lu[177Lu]PSMA-0057 injections as part of its nuclear medicine product pipeline[24]. - The company has initiated clinical trials for HLX79, a treatment for active renal glomerulonephritis, and HLX43, targeting advanced non-small cell lung cancer (NSCLC) in the U.S.[28].

Financial Performance - The company's operating revenue for Q3 2025 was ¥903,663,226.24, a decrease of 21.48% year-over-year, while the year-to-date revenue was ¥2,446,115,093.66, down 9.38% compared to the same period last year[5] - Net profit attributable to shareholders for Q3 2025 was ¥77,137,109.34, representing a decline of 37.26% year-over-year, and year-to-date net profit was ¥105,775,131.39, down 33.95% compared to the previous year[5] - The company's internet TV business revenue decreased by approximately 30% due to the impact of the terminal business divestiture[6] - Total operating revenue for the current period was ¥2,446,115,093.66, a decrease of 9.36% from ¥2,699,395,357.37 in the previous period[27] - Net profit for the current period was ¥77,066,510.41, a decline of 28.06% compared to ¥106,992,898.44 in the previous period[28] - The basic and diluted earnings per share for the current period were both ¥0.0967, down from ¥0.1482 in the previous period[30] - The company reported a comprehensive income total of ¥58,939,310.41, down from ¥86,076,898.44 in the previous period[28] Cash Flow and Investments - The company reported a net cash flow from operating activities of -¥114,884,312.63 for the year-to-date period, a significant decrease of 258.65% compared to the same period last year[5] - The net cash flow from operating activities was -114,884,312.63, a decrease of 258.65% compared to the previous period, primarily due to changes in project progress and customer payment schedules[17] - The net cash flow from investing activities improved by 55.62% to -228,569,723.00, mainly due to reduced settlement of engineering payments compared to the same period last year[17] - The net cash flow from financing activities was -626,141,028.24, a significant decrease of 440.97%, primarily due to loan repayments during the reporting period[17] - The net increase in cash and cash equivalents was -969,595,063.87, reflecting a 274.43% decline influenced by the aforementioned factors[17] - Cash received from sales of goods and services was 3,411,810,543.74 CNY, a decrease from 3,585,541,803.03 CNY in the previous period[31] - Total cash outflow from operating activities was 3,623,897,851.36 CNY, slightly down from 3,661,394,113.43 CNY in the previous period[31] - Cash paid for purchasing goods and services was 1,639,779,031.49 CNY, down from 1,797,559,707.22 CNY in the previous period[31] - Total cash inflow from investment activities was 783,972,084.84 CNY, compared to 160,685,988.83 CNY in the previous period[33] - Cash inflow from financing activities totaled 991,613,470.73 CNY, up from 770,465,500.00 CNY in the previous period[33] - The ending cash and cash equivalents balance was 550,843,868.03 CNY, down from 1,187,047,072.64 CNY in the previous period[33] Assets and Liabilities - The total assets at the end of Q3 2025 were ¥8,731,708,832.85, a decrease of 10.84% from the end of the previous year[5] - Total liabilities decreased to ¥2,290,544,340.26 from ¥3,241,797,219.48, reflecting a reduction of 29.43%[25] - Total equity attributable to shareholders of the parent company was ¥6,796,132,866.44, slightly down from ¥6,818,402,052.61[25] - Accounts receivable decreased from 2,220,242,327.35 to 1,568,905,926.81, indicating a reduction in outstanding payments[23] - Inventory increased significantly from 91,368,847.87 to 376,803,686.29, reflecting a strategic buildup of stock[24] - Total assets decreased from 9,792,773,457.42 to 8,731,708,832.85, indicating a reduction in overall company resources[23] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 34,646, with no preferred shareholders having restored voting rights[19] - The largest shareholder, Wuxi Puhua Equity Investment Partnership, holds 11.70% of shares, amounting to 126,402,660 shares, with 54,022,500 shares pledged[19] Research and Development - Research and development expenses were ¥371,809,181.03, a slight decrease from ¥376,423,362.88 in the previous period[28] - The company experienced a net investment income of ¥7,709,852.29, down from ¥12,771,736.17 in the previous period[28] - Other comprehensive income after tax was -¥18,127,200.00, compared to -¥20,916,000.00 in the previous period[28]

Financial Performance - The company's operating revenue for the third quarter was approximately CNY 986.58 million, a decrease of 0.81% compared to the same period last year[4] - The total profit for the year-to-date period was approximately CNY 11.82 million, reflecting a decrease of 7.17% year-on-year[4] - The net profit attributable to shareholders for the third quarter was approximately CNY 2.89 million, while the year-to-date net profit was approximately CNY 5.77 million[4] - Total operating revenue for the first three quarters of 2025 was CNY 2,963,304,503.96, a decrease of 7.16% compared to CNY 3,192,286,393.39 in the same period of 2024[19] - Net profit for the first three quarters of 2025 was CNY 17,170,404.21, a significant recovery from a net loss of CNY 5,084,136.03 in the same period of 2024[20] - The gross profit margin for the first three quarters of 2025 improved, with operating profit recorded at CNY 11,975,993.40 compared to a loss of CNY 16,691,786.46 in 2024[20] - The company reported a basic and diluted earnings per share of CNY 0.05 for the first three quarters of 2025, recovering from a loss of CNY 0.08 per share in the same period of 2024[21] Cash Flow - The net cash flow from operating activities for the third quarter was approximately CNY 34.48 million, down 22.14% compared to the previous year[4] - In the first three quarters of 2025, the net cash flow from operating activities was ¥160,476,330.60, compared to ¥164,801,030.17 in the same period of 2024, showing a slight decrease of 2%[22] - Total cash inflow from operating activities in 2025 was ¥3,484,495,442.36, while cash outflow was ¥3,324,019,111.76, resulting in a net cash inflow of ¥160,476,330.60[22] - Cash inflow from investment activities in 2025 was ¥43,748,990.56, significantly higher than ¥10,731,228.81 in 2024, marking an increase of approximately 307%[23] - The net cash flow from investment activities was -¥134,953,892.96 in 2025, compared to -¥380,964,245.69 in 2024, indicating an improvement of 64%[23] - Cash inflow from financing activities totaled ¥1,478,252,256.80 in 2025, while cash outflow was ¥1,526,411,124.63, resulting in a net cash outflow of -¥48,158,867.83[23] Assets and Liabilities - Total assets at the end of the reporting period were approximately CNY 5.39 billion, an increase of 5.46% from the end of the previous year[5] - The total liabilities increased to CNY 2.73 billion, compared to CNY 2.54 billion at the end of 2024, indicating a rise of approximately 7.5%[16] - Total liabilities increased to CNY 3,884,360,492.41 in 2025 from CNY 3,619,763,326.04 in 2024, reflecting a growth of 7.33%[19] - Total equity increased to CNY 1,503,416,488.70 in 2025 from CNY 1,489,268,484.22 in 2024, indicating a growth of 0.87%[19] Research and Development - Research and development expenses totaled approximately CNY 34.76 million for the quarter, representing 3.52% of operating revenue, an increase of 0.2 percentage points year-on-year[5] - Research and development expenses for the first three quarters of 2025 were CNY 100,707,191.80, up from CNY 95,908,291.01 in 2024, showing a year-over-year increase of 7.88%[19] Shareholder Information - The company’s major shareholder, Guangzhou Shipan Stone Investment Management Co., Ltd., holds a 39.43% stake, with no shares under pledge or freeze[12] Other Income - The company recognized government subsidies amounting to approximately CNY 17.09 million during the quarter, contributing to its non-recurring gains[7] - The company achieved investment income of CNY 17,007,477.31 in 2025, a significant increase from CNY 1,811,817.23 in 2024[19] Comprehensive Income - Other comprehensive income after tax for the first three quarters of 2025 was CNY -4,099,593.18, compared to CNY 1,803,925.78 in 2024, indicating a decline in comprehensive income[20] Current Assets - As of September 30, 2025, total current assets amounted to approximately CNY 2.60 billion, an increase from CNY 2.38 billion as of December 31, 2024, representing a growth of about 9.1%[15] - The company's cash and cash equivalents increased to CNY 179.81 million from CNY 151.82 million, reflecting a growth of approximately 18.5%[15] - Accounts receivable rose to CNY 1.08 billion, up from CNY 901.33 million, indicating an increase of around 20.2%[15] - The company's inventory decreased to CNY 724.12 million from CNY 754.13 million, showing a decline of about 4.0%[15] - The company reported a significant increase in other receivables, which rose to CNY 74.11 million from CNY 23.22 million, a growth of about 218.5%[15]

Financial Performance - The company's operating revenue for Q3 2025 was ¥633,730,137.99, a decrease of 3.72% compared to the same period last year[4] - The net profit attributable to shareholders was ¥49,594,564.94, down 21.39% year-on-year[4] - The net profit excluding non-recurring gains and losses was ¥46,626,498.14, a decline of 24.64% compared to the previous year[4] - Total operating revenue for the current period reached ¥1,774,878,152.34, an increase of 8.66% compared to ¥1,633,467,850.14 in the previous period[32] - Net profit for the current period was ¥170,719,517.81, representing a slight increase of 2.00% from ¥166,425,955.96 in the previous period[33] - Earnings per share (EPS) for the current period was ¥0.1997, compared to ¥0.1979 in the previous period[34] - The total comprehensive income for the current period was ¥189,207,652.45, compared to ¥175,215,618.21 in the previous period, reflecting an increase of 7.00%[34] Assets and Liabilities - The total assets at the end of the reporting period were ¥4,317,313,661.85, reflecting a 0.92% increase from the end of the previous year[4] - Total liabilities decreased to ¥952,584,531.34 from ¥1,047,846,316.91, reflecting a reduction of approximately 9.09%[31] - Total equity increased to ¥3,364,729,130.51, up from ¥3,229,988,114.87, indicating a growth of about 4.17%[31] - The company's cash and cash equivalents increased to RMB 1.15 billion from RMB 951.93 million at the beginning of the period[29] Cash Flow - The cash flow from operating activities for the year-to-date was ¥250,290,179.47, an increase of 30.62%[4] - Operating cash flow for the current period was ¥250,290,179.47, an increase of 30.6% compared to ¥191,612,437.55 in the previous period[35] - Cash received from operating activities totaled ¥1,810,016,612.77, an increase from ¥1,630,634,796.42 in the previous period[35] - Cash paid for purchasing goods and services was ¥914,130,060.85, up from ¥858,145,043.05 in the previous period[35] - Cash flow from financing activities resulted in a net outflow of -¥259,911,691.26, worsening from -¥137,446,605.90 in the previous period[36] - The net increase in cash and cash equivalents for the current period was ¥192,566,042.49, contrasting with a decrease of -¥278,278,662.37 in the previous period[36] - The ending balance of cash and cash equivalents reached ¥1,142,880,557.30, compared to ¥806,236,773.47 at the end of the previous period[36] Investments and Capital Expenditures - The company reported a significant decrease in receivables financing by 43.08% to ¥12,267,493.84 due to a reduction in bank acceptance bills[9] - Cash paid for the purchase of fixed assets decreased by 61.62% to ¥80,380,144.93, reflecting reduced capital expenditures compared to the previous year[14] - The investment income increased by 30.09% to ¥19,992,193.04, attributed to higher interest income from bank deposits[11] - Cash received from investment income was ¥46,378,582.73, significantly higher than ¥3,574,780.16 in the previous period[35] - Cash received from other investment activities rose by 106.30% to ¥897,813,237.84, attributed to the recovery of matured bank time deposits[14] - The company signed an investment agreement for a smart transmission system industrialization project in Kunshan, with a total planned investment of RMB 300 million, including RMB 210 million for fixed assets[23] Shareholder Information - The total number of common shareholders at the end of the reporting period was 25,904, with the largest shareholder holding 29.64% of the shares[15] - The largest shareholder, Shi Peihao, holds 241,007,477 shares, representing 29.64% of total shares[15] Corporate Governance - The company decided to abolish the supervisory board and revise its articles of association to enhance corporate governance[28]

二零二五年十月 西藏华钰矿业股份有限公司 2025 年第三季度报告 证券代码：601020 证券简称：华钰矿业 西藏华钰矿业股份有限公司 2025 年第三季度报告 1 / 21 西藏华钰矿业股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚 假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人: 刘良坤 主管会计工作负责人: 邢建军 及会计机构负责人（会计主管人 员）: 沈有德 保证季度报告中财务信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一）主要会计数据和财务指标 2 / 21 项目 本报告期 本报告期 比上年同 期增减变 动幅度 (%) 年初至报告期末 年初至报 告期末比 上年同期 增减变动 幅度(%) 营业收入 656,347,215.80 96.97 1,459,450,432.29 57.60 利润总额 672,060,305.05 ...

Financial Performance - The company's operating revenue for the third quarter reached ¥887,503,682.81, an increase of 55.36% compared to the same period last year[4] - The total profit for the third quarter was ¥158,331,890.98, while the net profit attributable to shareholders was ¥144,940,848.65, marking a significant recovery from previous losses[4] - The basic and diluted earnings per share for the third quarter were both ¥0.08, a notable improvement from a loss of ¥0.33 in the same period last year[5] - Total operating revenue for the first three quarters of 2025 reached ¥2,119,923,208.23, an increase of 32.4% compared to ¥1,600,579,847.51 in the same period of 2024[20] - The net loss for the first three quarters of 2025 was ¥562,700,855.02, compared to a net loss of ¥313,516,934.02 in the same period of 2024, indicating a deterioration in performance[21] - The basic and diluted earnings per share for the first three quarters of 2025 were both -¥0.33, compared to -¥0.15 in the same period of 2024[22] Assets and Liabilities - The total assets at the end of the reporting period were ¥29,741,516,402.20, reflecting a decrease of 2.34% from the end of the previous year[5] - Total liabilities amounted to ¥17,350,565,368.73, slightly down from ¥17,500,551,833.17 in the previous year[18] - Total assets decreased to ¥29,741,516,402.20 from ¥30,452,873,927.47 year-over-year[18] - The company's long-term borrowings decreased to ¥10,720,822,822.13 from ¥12,065,640,665.58, reflecting a strategic shift in financing[18] - The total equity attributable to shareholders decreased to ¥10,442,746,561.87 from ¥11,052,246,134.50, indicating a decline in shareholder value[18] Cash Flow - Cash flow from operating activities showed significant improvement due to a substantial increase in sales collections compared to the same period last year[10] - The company's cash flow from operating activities showed a significant decline, impacting liquidity and operational flexibility[23] - In the first three quarters of 2025, the cash inflow from operating activities reached ¥3,397,355,458.32, a significant increase of 44.6% compared to ¥2,351,225,400.03 in the same period of 2024[24] - The net cash flow from operating activities was -¥499,044,744.56, an improvement from -¥1,689,574,225.32 in the previous year, indicating a reduction in cash outflow[24] - Cash inflow from financing activities totaled ¥2,162,562,156.55, a decline of 62.3% from ¥5,741,775,488.75 in the same period last year[25] - The ending cash and cash equivalents balance was ¥3,704,609,225.49, an increase from ¥2,748,694,395.29 at the end of the same period last year[25] Shareholder Information - The company reported a total of 31,637 common shareholders at the end of the reporting period[12] - The largest shareholder, Shanghai Real Estate Development Co., Ltd., holds 48.60% of the shares, totaling 896,435,864 shares[12] Other Financial Metrics - Non-recurring gains and losses for the current period amounted to ¥10,265,582.02, contributing to the overall financial performance[8] - The increase in operating revenue was primarily driven by higher real estate sales and the recognition of construction income[9] - The company's inventory was reported at RMB 13,537,726,340.15, a slight decrease from RMB 13,799,805,306.71, indicating a reduction of approximately 1.9%[16] - The company’s other receivables decreased to RMB 175,170,276.59 from RMB 245,806,674.54, showing a decline of about 28.7%[16] - The company has not engaged in any share lending activities through margin trading or stock borrowing as of the third quarter of 2025[14] - The company completed the necessary business registration changes related to the amendments to its articles of association and the cancellation of the supervisory board as of September 2025[15] - The company has received RMB 1.6 billion in project management service fees from Shanghai Shisen Real Estate Co., Ltd. as part of a total expected payment of RMB 2 billion for services rendered between 2025 and 2026[15] - The company's long-term equity investments stood at RMB 5,047,903,732.34 as of September 30, 2025, slightly down from RMB 5,079,129,669.34 at the end of 2024[16] - The company did not apply new accounting standards for the current reporting period[26]

Financial Performance - The company's operating revenue for the third quarter was CNY 123,556,680.89, an increase of 9.17% compared to the same period last year[4]. - The net profit attributable to shareholders was CNY 58,793.00, representing a significant increase of 101.42% year-on-year[4]. - Total operating revenue for the first three quarters of 2025 was CNY 608.89 million, a decrease of 2.9% compared to CNY 622.78 million in the same period of 2024[19]. - Net profit for the first three quarters of 2025 was CNY 36.20 million, down 16.3% from CNY 43.28 million in the same period of 2024[20]. - The basic earnings per share for the third quarter was CNY 0.0004, up 101.42% year-on-year[5]. - The company reported a basic earnings per share of CNY 0.27, down from CNY 0.32 in the previous year[21]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 1,905,023,017.73, reflecting a growth of 2.31% from the end of the previous year[5]. - As of September 30, 2025, the company's total assets amounted to CNY 1,905,023,017.73, an increase from CNY 1,862,032,288.17 as of December 31, 2024[15]. - The company's current assets decreased to CNY 1,055,532,617.37 from CNY 1,096,712,579.53, reflecting a decline of approximately 3.75%[15]. - Total liabilities increased to CNY 757,685,954.66 from CNY 737,371,303.60, marking an increase of approximately 2.5%[17]. - The company's total liabilities decreased by 57.67% in accounts payable at the end of the reporting period[10]. - The company's equity attributable to shareholders rose to CNY 1,147,337,063.07 from CNY 1,124,660,984.57, an increase of about 2%[17]. Cash Flow - The cash flow from operating activities for the year-to-date was CNY 67,226,904.44, a decrease of 31.43% compared to the same period last year[5]. - Cash flow from operating activities generated a net amount of CNY 67.23 million, a decrease of 31.5% compared to CNY 98.05 million in the same period of 2024[23]. - Cash flow from investing activities resulted in a net outflow of CNY 101.78 million, an improvement from a net outflow of CNY 326.05 million in the previous year[24]. - Cash flow from financing activities generated a net inflow of CNY 68.81 million, compared to CNY 52.92 million in the same period of 2024, reflecting a 30% increase[24]. - The total cash and cash equivalents at the end of the period stood at CNY 254.47 million, compared to CNY 277.34 million at the end of the same period last year[24]. - Cash and cash equivalents increased to CNY 296,761,594.93 from CNY 267,862,944.94, representing an increase of about 10.5%[15]. Receivables and Inventory - The company reported a 248.42% increase in receivables financing due to an increase in bank acceptance bills received[9]. - Accounts receivable rose significantly to CNY 107,430,539.11 from CNY 57,741,288.18, indicating an increase of approximately 86.3%[15]. - The company experienced a 33.25% decrease in inventory as it consumed stock ahead of the winter storage period[10]. - Inventory decreased to CNY 176,687,991.37 from CNY 264,714,237.77, a decline of about 33.3%[15]. Expenses and Tax - Total operating costs decreased slightly to CNY 578.84 million from CNY 579.02 million year-on-year, with operating costs specifically down to CNY 405.52 million from CNY 431.27 million, a reduction of 5.9%[19]. - Research and development expenses increased to CNY 62.05 million, up 20.5% from CNY 51.45 million in the previous year[19]. - Tax expenses significantly decreased to CNY 105.42 million from CNY 7.98 million in the previous year, indicating a substantial reduction in tax liabilities[20]. Other Information - The company has not disclosed any new product developments or market expansion strategies in the current reporting period[14]. - The new accounting standards or interpretations will be implemented starting from 2025, affecting the financial statements from the beginning of that year[25].

Financial Performance - The company's operating revenue for the third quarter was CNY 595,385,679.34, representing a year-on-year increase of 3.05%[4] - The total profit for the quarter was CNY 199,189,270.09, showing a decrease of 13.65% compared to the same period last year[4] - The net profit attributable to shareholders was CNY 126,925,326.02, down 17.17% year-on-year[4] - The basic earnings per share for the quarter was CNY 0.1740, reflecting a decline of 17.18% compared to the previous year[5] - The company achieved operating revenue of RMB 1.535393 billion, an increase of RMB 123.5588 million, representing a growth of 8.75% year-on-year[12] - The net profit attributable to shareholders of the listed company was RMB 253.4906 million, a decrease of RMB 31.4066 million, reflecting a decline of 11.02% year-on-year, primarily due to increased resource usage fees[12] - Net profit for the first three quarters of 2025 was ¥274,752,462.92, a decrease of 12.2% from ¥312,750,418.44 in the same period of 2024[20] - The company reported a total comprehensive income of ¥276,577,662.92 for the first three quarters of 2025, down from ¥320,402,218.44 in the same period of 2024, a decrease of 13.7%[21] Assets and Liabilities - The total assets at the end of the reporting period amounted to CNY 5,913,341,552.50, an increase of 3.16% from the end of the previous year[5] - The total assets of the company as of the end of the reporting period were ¥5,913,341,552.50, up from ¥5,732,301,996.17 at the end of the previous period[16] - Total liabilities increased to ¥917,964,464.48, compared to ¥873,235,828.70 in the previous period, marking a rise of 5.2%[16] - The company's total current assets amounted to RMB 2.005 billion, slightly up from RMB 2.004 billion at the end of 2024[14] - The company's long-term equity investments decreased from RMB 185.0567 million to RMB 169.458 million[15] - The company's inventory decreased from RMB 47.9685 million to RMB 42.8945 million[15] - The company reported a total non-current asset value of RMB 3.9083 billion, an increase from RMB 3.7274 billion[15] Shareholder Information - The total equity attributable to shareholders increased to CNY 4,787,203,918.86, a rise of 2.79% from the previous year-end[5] - The equity attributable to shareholders of the parent company rose to ¥4,787,203,918.86, compared to ¥4,657,341,391.70 in the previous period, an increase of 2.8%[17] - The total number of ordinary shareholders at the end of the reporting period was 57,716[10] Cash Flow - The net cash flow from operating activities for the year-to-date was CNY 500,926,909.38, up 22.84% compared to the same period last year[4] - Cash generated from operating activities was ¥1,582,199,756.76 in the first three quarters of 2025, compared to ¥1,457,570,472.00 in the same period of 2024, reflecting an increase of 8.5%[23] - The net cash flow from operating activities was $500,926,909.38, an increase from $407,773,726.63 in the previous period, reflecting a growth of approximately 22.5%[24] - Total cash inflow from operating activities amounted to $1,894,963,101.24, compared to $1,732,651,185.79, indicating an increase of about 9.4%[24] - Cash outflow from operating activities was $1,394,036,191.86, up from $1,324,877,459.16, representing a rise of approximately 5.2%[24] Investments and Projects - Huangshan Cloud Fun Park Service Co., Ltd. was established to participate in bidding for state-owned land use rights, with the company successfully acquiring land use rights for a specific plot[13] - The non-public offering project for the renovation of the North Sea Hotel in Huangshan Scenic Area was completed and opened on September 20, 2025[13] Future Plans and Standards - The company plans to implement new accounting standards starting in 2025, which may affect the financial statements[26]

Financial Performance - Total revenue for Q3 2025 was CNY 1,779,624,436.56, representing a year-on-year increase of 1.60%[3] - Total profit for Q3 2025 decreased by 48.99% to CNY 31,271,489.09, primarily due to an asset impairment provision of CNY 87.39 million[8] - Net profit attributable to shareholders for Q3 2025 was CNY -20,697,775.37, a decline of 215.07% compared to the same period last year[3] - Basic earnings per share for Q3 2025 was CNY -0.0374, a decrease of 218.35% compared to the previous year[4] - Diluted earnings per share for Q3 2025 was also CNY -0.0374, reflecting the same decline as basic earnings per share[4] - Total operating revenue for the first three quarters of 2025 was CNY 4,882,725,420.04, a decrease of 3.58% compared to CNY 5,064,707,624.87 in the same period of 2024[18] - Net profit for the first three quarters of 2025 was CNY 99,811,535.89, a decline of 35.93% from CNY 155,770,824.64 in 2024[19] - Earnings per share for the first three quarters of 2025 was CNY 0.0404, compared to CNY 0.1075 in the same period of 2024, reflecting a decrease of 62.42%[20] - The company reported a total comprehensive income of CNY 99,350,877.53 for the first three quarters of 2025, down from CNY 155,545,250.46 in 2024[20] Cash Flow - The net cash flow from operating activities for the year-to-date period was CNY 142,994,179.28, down 70.91% year-on-year[4] - Cash inflow from operating activities for the first three quarters of 2025 was CNY 8,052,007,178.11, down 17.73% from CNY 9,786,943,820.66 in 2024[21] - The net cash flow from operating activities was $142,994,179.28, a decrease of 70.1% compared to $491,485,881.02 in the previous period[22] - Cash outflows from operating activities totaled $7,909,012,998.83, down 15% from $9,295,457,939.64[22] - The net cash flow from investing activities was -$812,114,768.11, worsening from -$559,226,717.58 in the prior period[22] - Cash inflows from investing activities amounted to $962,236,785.31, an increase of 102.5% compared to $474,591,367.08[22] - Cash outflows for investments reached $1,774,351,553.42, up 71.7% from $1,033,818,084.66[22] - The net cash flow from financing activities was -$118,334,368.96, an improvement from -$197,891,861.30 in the previous period[22] - Cash inflows from financing activities totaled $251,400,061.80, a decrease of 33.7% compared to $379,031,704.64[22] - Cash and cash equivalents decreased by $787,298,670.87, compared to a decrease of $265,489,331.44 in the prior period[22] - The beginning balance of cash and cash equivalents was $3,069,000,613.42, up from $2,881,756,534.94[22] Assets and Liabilities - Total assets at the end of the reporting period were CNY 10,029,241,336.29, a decrease of 0.69% from the end of the previous year[4] - Total current assets increased to ¥6,789,647,505.73 from ¥6,700,412,176.56 year-over-year[14] - Accounts receivable rose to ¥2,236,944,142.53, compared to ¥1,849,728,373.90 in the previous year[14] - Total current liabilities are reported at ¥4,312,601,400.67, a slight decrease from ¥4,348,655,662.00[15] - The company has a long-term investment of ¥1,609,360,323.66, down from ¥1,646,346,171.84[14] - Total liabilities as of the end of the reporting period were CNY 4,535,575,004.86, slightly down from CNY 4,571,689,603.47[16] - Total non-current liabilities are reported at ¥222,973,604.19, showing a minor decrease from ¥223,033,941.47[15] - Total equity attributable to shareholders was CNY 4,584,849,752.57, a slight increase from CNY 4,580,718,200.23[16] - Shareholders' equity attributable to the parent company was CNY 4,584,849,752.57, showing a slight increase of 0.09% compared to the previous year[4] Shareholder Information - The total number of common shareholders at the end of the reporting period is 29,426[11] - Dongfeng Automotive Parts (Group) Co., Ltd. holds 413,472,051 shares, representing 74.77% of total shares[12] - The company has no significant changes in shareholder participation in financing or securities lending activities[12] Future Outlook - The company plans to continue focusing on asset impairment management and improving cash flow from operations in the upcoming quarters[8] - The company will not apply new accounting standards starting from 2025[23] Research and Development - Research and development expenses for the first three quarters of 2025 were CNY 237,307,374.93, a decrease of 7.36% from CNY 256,219,907.28 in 2024[19] Investment Income - The company experienced a decrease in investment income, reporting CNY 124,779,696.04 for the first three quarters of 2025, compared to CNY 116,427,865.03 in 2024, indicating a growth of 7.06%[19]

Financial Performance - Q3 2025 revenue was CNY 420,751,448.09, a decrease of 2.64% year-over-year, while year-to-date revenue reached CNY 1,245,550,721.58, an increase of 5.67%[5] - Net profit attributable to shareholders for Q3 2025 was CNY 46,146,558.22, up 28.37% year-over-year, with year-to-date net profit at CNY 132,871,566.01, an increase of 23.40%[5] - Basic earnings per share for Q3 2025 was CNY 0.1349, reflecting a 28.35% increase compared to the same period last year[5] - Total operating revenue for the current period reached ¥1,245,550,721.58, an increase of 5.7% compared to ¥1,178,749,427.99 in the previous period[20] - Net profit for the current period was ¥158,825,051.08, representing a 19.9% increase from ¥132,355,727.85 in the previous period[21] - Earnings per share (EPS) for the current period was ¥0.3883, compared to ¥0.3136 in the previous period, indicating a growth of 23.8%[22] - The company’s total comprehensive income for the current period was ¥158,520,995.38, up from ¥132,108,825.03, indicating a growth of 19.9%[22] Cash Flow - The net cash flow from operating activities for the year-to-date period increased by 405.55% to CNY 205,530,918.26[5] - Cash flow from operating activities generated a net amount of ¥205,530,918.26, significantly higher than ¥40,655,275.67 in the previous period[23] - Cash flow from investment activities showed a net outflow of -$205.15 million, a significant decrease compared to a net inflow of $30.21 million in the previous period[24] - Cash flow from financing activities resulted in a net outflow of -$210.15 million, improving from a net outflow of -$311.03 million year-over-year[24] - The net cash increase for the period was -$210.60 million, compared to -$240.49 million in the previous period[24] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,210,826,381.52, a 0.73% increase from the end of the previous year[5] - Total current assets amount to ¥1,995,035,065.08, an increase from ¥1,952,545,734.64 at the beginning of the period[17] - Total liabilities decreased to ¥1,278,116,690.01 from ¥1,361,359,151.02, a reduction of approximately 6.1%[20] - The company reported a 44.39% decrease in cash and cash equivalents compared to the beginning of the year, mainly due to investments in financial products and cash dividends paid[9] - Total liabilities include accounts payable of ¥372,705,943.84, up from ¥350,684,345.72[17] Shareholder Information - Total number of common stock shareholders at the end of the reporting period is 36,590[14] - The largest shareholder, Ming Gang, holds 24.36% of shares, totaling 84,678,273 shares[14] Expenses - The company experienced a 31.20% decrease in financial expenses year-over-year, attributed to reduced interest expenses[11] - Total operating costs amounted to ¥1,092,901,978.50, up from ¥1,052,828,833.17, reflecting a year-over-year increase of 3.8%[20] - Research and development expenses increased to ¥74,932,446.27, up from ¥60,559,245.24, marking a rise of 23.7%[21] Borrowings and Financing - The company's long-term borrowings increased by 213.72% to CNY 9,190,000, indicating a significant rise in financing activities[10] - Short-term borrowings decreased to ¥388,000,000.00 from ¥536,800,000.00, a reduction of approximately 28.0%[17] - Cash inflow from borrowing was $429.90 million, down from $554.90 million in the prior period[24] - Cash outflow for debt repayment was $577.41 million, a decrease from $743.04 million year-over-year[24] Accounting and Reporting - The company did not undergo an audit for the third quarter financial report[25] - The new accounting standards will be first implemented starting in 2025[26]